Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Farmers Insurance
UBS
Novartis
AstraZeneca
Fish and Richardson
US Army
Mallinckrodt
Harvard Business School

Generated: February 21, 2018

DrugPatentWatch Database Preview

Ketoprofen - Generic Drug Details

« Back to Dashboard

What are the generic sources for ketoprofen and what is the scope of ketoprofen freedom to operate?

Ketoprofen
is the generic ingredient in six branded drugs marketed by Actavis Labs Fl Inc, Alkermes Gainesville, Mylan, Wyeth Pharms Inc, Aurolife Pharma Llc, Heritage Pharms Inc, Teva, Wyeth Ayerst, Novartis, Bayer, Perrigo, and Wyeth Cons, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for ketoprofen. Fifteen suppliers are listed for this compound.
Pharmacology for ketoprofen
Medical Subject Heading (MeSH) Categories for ketoprofen

US Patents and Regulatory Information for ketoprofen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva KETOPROFEN ketoprofen CAPSULE;ORAL 073515-001 Dec 22, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Cons ORUDIS KT ketoprofen TABLET;ORAL 020429-001 Oct 6, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alkermes Gainesville KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 074879-001 Dec 10, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan KETOPROFEN ketoprofen CAPSULE;ORAL 074035-002 Dec 31, 1996 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075270-001 Mar 24, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075679-002 Feb 20, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075679-001 Feb 20, 2002 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-003 Jan 9, 1986 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Labs Fl Inc KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075270-003 Mar 24, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan KETOPROFEN ketoprofen CAPSULE, EXTENDED RELEASE;ORAL 075679-003 Feb 20, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ketoprofen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-001 Jul 31, 1987 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-002 Jan 9, 1986 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst ORUDIS ketoprofen CAPSULE;ORAL 018754-003 Jan 9, 1986 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Baxter
Healthtrust
Fish and Richardson
Boehringer Ingelheim
Merck
Teva
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot